How different brain cells in the reward center respond to opioids
Role of novel VTA neurons in addiction-related behaviors
This work looks at how different nerve cells in a key brain reward area react to opioids and influence addictive behavior to help people with opioid problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11261189 on NIH RePORTER |
What this research studies
Researchers are mapping how three kinds of chemical signals—dopamine, GABA, and glutamate—released by neurons in the ventral tegmental area (VTA) change motivated and opioid-related behaviors. They will use laboratory animal models (typically rodents) to record and manipulate specific VTA neuron populations and their inputs while measuring reward- and opioid-linked behaviors. The team will examine cells that release single transmitters and cells that co-release multiple transmitters to see how each alters reinforcement. The goal is to identify which cell types and circuits drive opioid seeking and relapse.
Who could benefit from this research
Good fit: This is a preclinical, lab-based project that does not enroll people, but its findings are most relevant to individuals with opioid use disorder and others affected by addiction.
Not a fit: People seeking immediate clinical treatment, those without opioid-related problems, or anyone expecting ready-to-use therapies are unlikely to receive direct benefit from this basic research.
Why it matters
Potential benefit: If successful, this could point to new brain-cell targets for medications or other therapies to reduce opioid craving and relapse.
How similar studies have performed: Previous animal research has established that VTA dopamine neurons shape reward and addiction, while studies targeting VTA GABA and glutamate neurons or co-release are newer and still experimental.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Hnasko, Thomas — University of California, San Diego
- Study coordinator: Hnasko, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.